These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9474070)

  • 1. Dyspepsia: how should we measure it?
    Kuykendall DH; Rabeneck L; Campbell CJ; Wray NP
    J Clin Epidemiol; 1998 Feb; 51(2):99-106. PubMed ID: 9474070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
    Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
    Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New psychometric data from the Spanish versions of the Glasgow Dyspepsia Severity Score and the Dyspepsia-Related Health Scale measures.
    Orive M; Antón-Ladislao A; González N; Matellanes B; Padierna JÁ; Cabriada JL; Orive A; Manuel Orive V; Quintana JM
    Rev Esp Enferm Dig; 2018 Jan; 110(1):10-18. PubMed ID: 29144152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health.
    Rabeneck L; Cook KF; Wristers K; Souchek J; Menke T; Wray NP
    J Clin Epidemiol; 2001 Aug; 54(8):755-65. PubMed ID: 11470383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy.
    Rabeneck L; Wristers K; Goldstein JL; Eisen G; Dedhiya SD; Burke TA
    Am J Gastroenterol; 2002 Jan; 97(1):32-9. PubMed ID: 11808967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial linguistic and psychometric validation of the Arabic version of Nepean Dyspepsia Index.
    Khalil MS; Wahass SH; Al-Qourain AA; Yassawy MI
    Saudi Med J; 2006 Oct; 27(10):1554-60. PubMed ID: 17013482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms.
    Garratt AM; Ruta DA; Russell I; Macleod K; Brunt P; McKinlay A; Mowat A; Sinclair T
    J Clin Epidemiol; 1996 May; 49(5):565-71. PubMed ID: 8636730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial.
    Cook KF; Rabeneck L; Campbell CJ; Wray NP
    J Clin Epidemiol; 1999 May; 52(5):381-92. PubMed ID: 10360332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.
    Nakada K; Matsuhashi N; Iwakiri K; Oshio A; Joh T; Higuchi K; Haruma K
    World J Gastroenterol; 2017 Jul; 23(28):5216-5228. PubMed ID: 28811716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
    Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K
    Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders.
    Rentz AM; Kahrilas P; Stanghellini V; Tack J; Talley NJ; de la Loge C; Trudeau E; Dubois D; Revicki DA
    Qual Life Res; 2004 Dec; 13(10):1737-49. PubMed ID: 15651544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring dyspepsia-related health in randomized trials: the Severity of Dyspepsia Assessment (SODA) and its use in treatment with NSAIDs and COX-2-specific inhibitors.
    Rabeneck L
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii32-9. PubMed ID: 14585916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pain disability questionnaire: a new psychometrically sound measure for chronic musculoskeletal disorders.
    Anagnostis C; Gatchel RJ; Mayer TG
    Spine (Phila Pa 1976); 2004 Oct; 29(20):2290-302; discussion 2303. PubMed ID: 15480144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nepean Dyspepsia Index is a valid instrument for measuring quality-of-life in functional dyspepsia.
    Jones MP; Sato YA; Talley NJ
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):329-333. PubMed ID: 30461521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychometric validation of the Polish translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) Questionnaire in patients with reflux disease].
    Kulich KR; Reguła J; Stasiewicz J; Jasinski B; Carlsson J; Wiklund I
    Pol Arch Med Wewn; 2005 Mar; 113(3):241-9. PubMed ID: 16128281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-cultural adaptation and validation of the Quebec Back Pain Disability Scale to European Portuguese language.
    Cruz EB; Fernandes R; Carnide F; Vieira A; Moniz S; Nunes F
    Spine (Phila Pa 1976); 2013 Nov; 38(23):E1491-7. PubMed ID: 23887443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Kinyarwanda-version Short-Form Leeds Dyspepsia Questionnaire and Short-Form Nepean Dyspepsia Index to assess dyspepsia prevalence and quality-of-life impact in Rwanda.
    Nkurunziza A; Dusabejambo V; Everhart K; Bensen S; Walker T
    BMJ Open; 2016 Jun; 6(6):e011018. PubMed ID: 27266772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q).
    Ruiz MA; Pardo A; Rejas J; Soto J; Villasante F; Aranguren JL
    Value Health; 2008; 11(5):913-26. PubMed ID: 18494753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.
    Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
    Qual Life Res; 2004 May; 13(4):833-44. PubMed ID: 15129893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the EQ-5D in patients with irritable bowel syndrome.
    Bushnell DM; Martin ML; Ricci JF; Bracco A
    Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.